Skip to content
HowShorted

SELLAS Life Sciences Group, Inc. short interest in 2024

In 2024, SELLAS Life Sciences Group, Inc.'s disclosed short interest ran from 12.11% of shares outstanding on 12 Jan 2024 to 11.33% on 31 Dec 2024, a change of -0.78 percentage points. The year's high was 18.93% on 31 Jul 2024 and its low 9.37% on 28 Mar 2024, averaging 12.84% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.02 days on 13 Sep 2024. Full history: SELLAS Life Sciences Group, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SELLAS Life Sciences Group, Inc. in 2024

2024 in figures

Start of year
12.11% (12 Jan 2024)
End of year
11.33% (31 Dec 2024)
Change
-0.78 pp
High
18.93% (31 Jul 2024)
Low
9.37% (28 Mar 2024)
Average
12.84%
Highest days to cover
18.02 (13 Sep 2024)
SEC filings marked
8

Every report in 2024

SELLAS Life Sciences Group, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202412.11%1.85
31 Jan 20249.72%2.89
15 Feb 202412.12%3.83
29 Feb 202414.08%5.96
15 Mar 202416.16%2.83
28 Mar 20249.37%2.8110-K filed, results (8-K)
15 Apr 202410.07%3.57
30 Apr 202412.43%4.73
15 May 202412.89%4.4610-Q filed, results (8-K)
31 May 202413.59%10.95
14 Jun 202413.42%7.46
28 Jun 202415.75%5.11
15 Jul 202417.28%17.01
31 Jul 202418.93%9.62
15 Aug 202412.00%12.6210-Q filed, results (8-K)
30 Aug 202412.77%16.75
13 Sep 202412.69%18.02
30 Sep 202412.71%17.51
15 Oct 20249.46%12.46
31 Oct 202413.39%13.14
15 Nov 202412.45%11.1710-Q filed, results (8-K)
29 Nov 202412.86%8.83
13 Dec 202410.59%3.51
31 Dec 202411.33%7.20

See also: SELLAS Life Sciences Group, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.